Dehydroepiandrosterone (DHEA) treatment for poor responders in IVF patients: a prospective randomised controlled trial

被引:0
|
作者
Viardot-Foucault, V. [1 ]
Tai, B. C. [2 ]
Ng, X. W. [1 ]
Chen, Z. J. [2 ]
Lau, M. S. K. [1 ]
Nadarajah, S. [1 ]
Tan, H. H. [1 ]
Chan, J. K. Y. [1 ]
机构
[1] KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore
[2] Natl Univ Hlth Syst, Invest Med Unit, Singapore, Singapore
关键词
dehydroepiandrosterone; ICSI; poor ovarian responders; diminished ovarian reserve; outcomes;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-692
引用
收藏
页码:417 / 418
页数:2
相关论文
共 50 条
  • [1] Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders
    Triantafyllidou, Olga
    Sigalos, George
    Vlahos, Nikos
    [J]. HUMAN FERTILITY, 2017, 20 (02) : 80 - 87
  • [2] Dehydroepiandrosterone (DHEA) administration prior to IVF in poor responders. A prospective cohort study
    Vlahos, N.
    Papalouka, M.
    Triantafyllidou, O.
    Vlachos, A.
    Vakas, P.
    Crimbizis, G.
    Creatsas, G.
    Zikopoulos, K.
    [J]. HUMAN REPRODUCTION, 2014, 29 : 219 - 219
  • [3] A prospective randomised controlled study (RCT) on role of dehydroepiandrosterone (DHEA) on improving the ovarian response in known poor responders in previous failed IVF-ICSI cycle
    Jindal, A.
    Singh, R.
    [J]. HUMAN REPRODUCTION, 2014, 29 : 14 - 14
  • [4] Dehydroepiandrosterone (DHEA) adjuvant and poor ovarian responders
    Lee, Wen-Ling
    Yang, Szu-Ting
    Wang, Peng-Hui
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2022, 61 (04): : 571 - 572
  • [5] Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study
    Vlahos, Nikos
    Papalouka, Maria
    Triantafyllidou, Olga
    Vlachos, Athanasios
    Vakas, Panagiotis
    Grimbizis, Gregory
    Creatsas, George
    Zikopoulos, Konstantinos
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 30 (02) : 191 - 196
  • [6] Role of transdermal testosterone gel pretreatment in poor responders on IVF outcome - a prospective randomised controlled trial with active control
    Padmashri, P.
    Singh, N.
    Kumar, S.
    Perumal, V
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 207 - 207
  • [7] DEHYDROEPIANDROSTERONE (DHEA) SUPPLEMENTATION FOR POOR RESPONDERS - HOW DOES IT WORK?
    Margalioth, E. J.
    Rabinowitz, R.
    Tsafrir, A.
    Algur, N.
    Eldar-Geva, T.
    [J]. FERTILITY AND STERILITY, 2010, 94 (04) : S86 - S86
  • [8] Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study
    Wiser, A.
    Gonen, O.
    Ghetler, Y.
    Shavit, T.
    Berkovitz, A.
    Shulman, A.
    [J]. HUMAN REPRODUCTION, 2010, 25 (10) : 2496 - 2500
  • [9] Authors' reply: Effect of dehydroepiandrosterone administration before IVF on the live birth rate in poor ovarian responders according to the Bologna criteria: a randomised controlled trial
    Wang, Ze
    Shi, Yuhua
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (09) : 1611 - 1611
  • [10] Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial
    Caprio, Francesca
    D'Eufemia, Maria Diletta
    Trotta, Carlo
    Campitiello, Maria Rosaria
    Ianniello, Raffaele
    Mele, Daniela
    Colacurci, Nicola
    [J]. JOURNAL OF OVARIAN RESEARCH, 2015, 8